Mereo BioPharma Group plc American Depositary Shares (MREO) is a publicly traded Healthcare sector company. As of May 21, 2026, MREO trades at $0.29 with a market cap of $37.89M and a P/E ratio of -5.44. MREO moved +20.25% today. Year to date, MREO is -41.18%; over the trailing twelve months it is -87.71%. Its 52-week range spans $0.20 to $4.72. Analyst consensus is buy with an average price target of $2.33. Rallies surfaces MREO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Mereo BioPharma Group plc American Depositary Shares (MREO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MREO moved +20.25% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.29 |
| Market Cap | $37.89M |
| P/E Ratio | -5.44 |
| EPS | $-0.05 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.72 |
| 52-Week Low | $0.20 |
| Volume | 2.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $500.00K |
| Net Income | $-41.88M |
| Gross Margin | 0.00% |
5 analysts cover MREO: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.33.